Company: PGEN
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001356090-25-000019
Chunk: 6

Company: PRECIGEN, INC.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part II, Item 1A
Chunk 6
---
 Reporting Language)). Attached as Exhibit 101.0 to this Quarterly Report on Form 10-Q are the following documents formatted in XBRL: (i) the Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024, (ii) the Condensed Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024, (iii) the Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2025 and 2024, (iv) the Condensed Consolidated Statements of Mezzanine Equity and Shareholders' Equity (Deficit) for the three months ended March 31, 2025 and 2024, (v) the Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024, and (vi) the Notes to the Condensed Consolidated Financial Statements.104** Cover Page Interactive Data File (embedded within the Inline XBRL document).

**    Furnished herewith.

37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 Precigen, Inc. (Registrant)Date: May 14, 2025 By: /s/  HARRY THOMASIAN JR.  Harry Thomasian Jr.  Chief Financial Officer  (Principal Financial and Accounting Officer)

38